Odyssey Therapeutics, Inc. (ODTX) Live Share Price, Invest From India

Odyssey Therapeutics, Inc. Stock Performance

as on September 19, 2026 at 2:16 pm IST

Day's Low
Day's High
$23.00
Day's Price Range
$25.15
$24.38
5.66%
Downside
3.16%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$24.38
100.00%
Downside
-100.00%
Upside

Odyssey Therapeutics, Inc. share price movements today

Previous Close: $23.22
Open: $23.79
Volume: 406.7K
Market Cap: $1.1B
Day's Low - High: $23.00 - $25.15

Odyssey Therapeutics, Inc. Historical Returns

1 Month Return: -4.25 %
3 Month Return: + 21.76 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Odyssey Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Odyssey Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.1B

EPS (TTM)

-2.55

Dividend Yield

0.00%

PE Ratio (TTM)

-9.11

Industry PE ratio

-6.87

PEG Ratio

-0.09105882352941178

Return On Equity TTM

177.71%

Odyssey Therapeutics, Inc. Stock Valuation

Track how Odyssey Therapeutics, Inc. P/E has moved over time to understand its valuation trends.

Odyssey Therapeutics, Inc. in the last 1 year

Overview
Trends

Lowest (-3.05x)

December 31, 2025

Industry (-6.87x)

December 31, 2025

Today (-3.05x)

December 31, 2025

Highest (-3.05x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -3.05x

Odyssey Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Odyssey Therapeutics, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Odyssey Therapeutics, Inc.	StrongBuy	$1.1B	NA	-9.11	0.00%	0.00%
Moderna	BUY	$63.1B	-63.24%	-19.81	-12.57%	0.00%
Vertex Pharmaceuticals	BUY	$130.1B	174.21%	29.81	86.04%	0.00%
Regeneron	BUY	$79.7B	21.1%	18.48	84.86%	0.48%

Analyst Recommendation on Odyssey Therapeutics, Inc. Stock

Based on 4 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for Odyssey Therapeutics, Inc.. Average target price of $34.3333333333333

Indian Investors' Interest in Odyssey Therapeutics, Inc. Stock

Search interest for Odyssey Therapeutics, Inc. Stock has increased by 56% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 22, 2026 to September 21, 2026

Change:56% versus previous 30 day period

Odyssey Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2026	Jun 2026
Total Revenue	-	-
Gross Profit	-	-
Operating Income	-39	-55
EBITDA	-37	-51
Interest Expense	0	0
Depreciation	1	1
Income Before Tax	-38	-52
Income Tax Expense	0	0
Net Income	-38	-52
Net Profit Margin	0.00%	0.00%

Odyssey Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2025
Total Revenue	2
Gross Profit	2
Operating Income	-161
EBITDA	-144
Interest Expense	0
Depreciation	4
Income Before Tax	-149
Income Tax Expense	0
Net Income	-148
Net Profit Margin	100.00%

Odyssey Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2026	Jun 2026
Net Income	-38	-52
Operating Cash Flow	-41	-34
Investing Cash Flow	34	-211
Financing Cash Flow	0	292
Change in Cash	-5	46

Odyssey Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2025
Net Income	-148
Operating Cash Flow	-129
Investing Cash Flow	-103
Financing Cash Flow	215
Change in Cash	-17

Global Institutional Holdings in Odyssey Therapeutics, Inc.

Funds	Holdings
James E. Flynn	2.18%
Vanguard	1.51%
Michael Rockefeller	0.72%
Schwab	0.18%
Morgan Stanley	0.01%

See all

Insights on Odyssey Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 months, ODTX stock has moved up by 27.8%

About Odyssey Therapeutics, Inc.

Odyssey Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on discovering and developing novel treatments for autoimmune and inflammatory diseases. Its diverse pipeline features several key drug candidates: OD-001, an oral small molecule that inhibits receptor-interacting protein kinase 2, which is currently in Phase 2a clinical trials for ulcerative colitis. Also included is OD-002, an oral small molecule SLC15A4 inhibitor engineered to prevent harmful inflammatory responses driven by TLR7/8/9-mediated activation of interferon regulatory factor 5 (IRF5). Another program, OD-003, is a protein therapeutic designed to selectively agonize tumor necrosis factor receptor 2 on T regulatory cells. Further assets in its portfolio comprise a bispecific antagonist targeting TSLP and IL-33, an oral small molecule functioning as an interleukin-1 receptor-associated kinase 4 scaffolding inhibitor, and a separate small molecule inhibitor specifically targeting IRF5. The company was founded in 2021 and is headquartered in Boston, Massachusetts.

Organisation	Odyssey Therapeutics, Inc.
Headquarters	51 Sleeper Street, Boston, MA, 02210, US
Industry	Biotechnology
CEO	Gary D. Glick
E-voting on shares	Click here to vote

Key Management of Odyssey Therapeutics, Inc.

Name	Title
Dr. Joseph McDonald Ph.D.	Chief Data Officer
Dr. Gary D. Glick Ph.D.	Founder, President, CEO & Director
Mr. Collin Todd	Senior Vice President of Strategy & Business Development
Dr. Kim Lewis Ph.D.	Scientific Co-Founder
Dr. Felix Meissner Ph.D.	Scientific Co-Founder
Dr. Florian.I Schmidt Ph.D.	Scientific Co-Founder
Mr. Jason Haas M.B.A.	Chief Financial Officer
Prof. Eicke Latz M.D., Ph.D.	Scientific Co-Founder
Ms. Jolie M. Siegel J.D.	Executive VP, General Counsel & Secretary
Dr. Natalie Dales Ph.D.	Chief of Research Operations & Portfolio Strategy

FAQs

What is Odyssey Therapeutics, Inc. share price today?

Odyssey Therapeutics, Inc. share price today is $24.38 as on September 19, 2026 at 8:46 am IST at the close of the market. Odyssey Therapeutics, Inc. share today touched a day high of $25.15 and a low of $23.00.

What is the 52 week high and 52 week low for Odyssey Therapeutics, Inc. share?

Odyssey Therapeutics, Inc. share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Odyssey Therapeutics, Inc. stock price today i.e. September 19, 2026 at 8:46 am IST is closed at $24.38,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Odyssey Therapeutics, Inc.'s market capitalisation today?

Odyssey Therapeutics, Inc. market capitalisation is $0.00T as on September 19, 2026 at 8:46 am IST.

How to invest in Odyssey Therapeutics, Inc. Stock (ODTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Odyssey Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Odyssey Therapeutics, Inc. Shares that will get you 0.0615 shares as per Odyssey Therapeutics, Inc. share price of $24.38 per share as on September 19, 2026 at 8:46 am IST.

What is the minimum amount required to buy Odyssey Therapeutics, Inc. Stock (ODTX) from India?

Indian investors can start investing in Odyssey Therapeutics, Inc. (ODTX) shares with as little as ₹95.88 or $1 (as of September 21, 2026 at 12:38 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹958.80 in Odyssey Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on September 21, 2026 at 12:38 am IST). Based on Odyssey Therapeutics, Inc. share’s latest price of $24.38 as on September 19, 2026 at 8:46 am IST, you will get 0.4102 shares of Odyssey Therapeutics, Inc.. Learn more about fractional shares .